Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Hannes Wandt"'
Autor:
Christian Straka, Peter Liebisch, Hans Salwender, Burkhard Hennemann, Bernd Metzner, Stefan Knop, Sigrid Adler-Reichel, Christian Gerecke, Hannes Wandt, Martin Bentz, Tim Hendrik Bruemmendorf, Marcus Hentrich, Michael Pfreundschuh, Hans-Heinrich Wolf, Orhan Sezer, Ralf Bargou, Wolfram Jung, Lorenz Trümper, Bernd Hertenstein, Else Heidemann, Helga Bernhard, Nicola Lang, Norbert Frickhofen, Holger Hebart, Ralf Schmidmaier, Andreas Sandermann, Tobias Dechow, Albrecht Reichle, Brigitte Schnabel, Kerstin Schäfer-Eckart, Christian Langer, Martin Gramatzki, Axel Hinke, Bertold Emmerich, Hermann Einsele
Publikováno v:
Haematologica, Vol 101, Iss 11 (2016)
Autologous transplantation is controversial for older patients with multiple myeloma. The role of age-adjusted high-dose melphalan and the impact of induction chemotherapy cycles is still unclear. A total of 434 patients aged 60–70 years were rando
Externí odkaz:
https://doaj.org/article/8484c26faddc436abed9f7a934ff997e
Autor:
Hans-Heinrich Wolf, Bernd Metzner, Wolf Rösler, Jürgen Müller, Wolfram Jung, Florian Bassermann, Martin Gramatzki, Christian Langer, Hannes Wandt, Monika Engelhardt, Peter Liebisch, Hans Salwender, Hermann Einsele, Martin Kropff, Thomas Fischer, Martin Vogel, Herbert G. Sayer, Christian Straka, Wolfram Brugger, Heinz Dürk, Stefan Knop
Publikováno v:
European journal of haematologyREFERENCES. 103(3)
Objective A post hoc analysis of two phase III trials was carried out to explore the influence of age and treatment factors on the effect of bortezomib consolidation on progression-free survival (PFS) post autologous stem cell transplantation (ASCT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78f3ba2750a9a4e00e1b4234a096b11a
https://pubmed.ncbi.nlm.nih.gov/31231828
https://pubmed.ncbi.nlm.nih.gov/31231828
Publikováno v:
ISBT Science Series. 11:178-181
Nearly, all patients, whether receiving treatment with autologous hematopoietic stem cell transplantation (autoHSCT), intensive chemotherapy or allogeneic HSCT (alloHSCT), will receive one or more transfusions of platelets, most as prophylaxis. Optim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b08fc0c14cf92f54577c988ce24ac9a2
https://doi.org/10.1111/voxs.12198
https://doi.org/10.1111/voxs.12198
Autor:
Ulrich Keller, Vindi Jurinovic, Oliver Weigert, Hannes Wandt, Peter Dreger, Norbert Schmitz, Michael Pfreundschuh, Martin Dreyling, Bernd Metzner, Michael Unterhalt, Wolfgang Hiddemann, Eva Hoster
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(6)
Patients with follicular lymphoma (FL) and progression of disease (POD) within 24 months after frontline treatment (POD24) have poor overall survival (OS). The optimal salvage treatment for these patients is unknown. We assessed the role of high-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366c392068a5ab296d512db99c1451d7
https://pubmed.ncbi.nlm.nih.gov/29605716
https://pubmed.ncbi.nlm.nih.gov/29605716
Autor:
Alwin Krämer, Stefan W. Krause, Christian Thiede, Hannes Wandt, Hubert Serve, Claudia D. Baldus, Uwe Platzbecker, Gerhard Ehninger, Mathias Hänel, Christoph Röllig, Anthony D. Ho, Walter E. Aulitzky, Norbert Schmitz, Carsten Müller-Tidow, Malte von Bonin, Markus Schaich, Hermann Einsele, Friedrich Stölzel, Martin Wermke, Wolfgang E. Berdel, Michael Kramer, Matthias Stelljes, Johannes Schetelig, Kerstin Schäfer-Eckart, Utz Krug, Martin Bornhäuser
Publikováno v:
Journal of Clinical Oncology. 33:403-410
Purpose The presence of a mutated nucleophosmin-1 gene (NPM1mut) in acute myeloid leukemia (AML) is associated with a favorable prognosis. To assess the predictive value with regard to allogeneic stem-cell transplantation (SCT), we compared the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7382214cd19f1673351b85e6bef74de9
https://doi.org/10.1200/jco.2013.54.4973
https://doi.org/10.1200/jco.2013.54.4973
Autor:
Heinz Dürk, Martin Gramatzki, Hans-Heinrich Wolf, Stefan Knop, Hannes Wandt, Monika Engelhardt, Herbert G. Sayer, Christian Straka, Wolf Rösler, Wolfram Jung, Bernd Metzner, H. Einsele, Peter Liebisch, Martin Kropff, Wolfram Brugger, Christian Langer, Martin Vogel, Hans Salwender, Jürgen Müller, Thomas Fischer, Florian Bassermann
Publikováno v:
Leukemia. 31(6)
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c50329ece23f69a8cd874a6512b79cb
https://pubmed.ncbi.nlm.nih.gov/28293022
https://pubmed.ncbi.nlm.nih.gov/28293022
Autor:
Orhan Sezer, Christian Gerecke, Hans-Heinrich Wolf, Christian Langer, Ralf Schmidmaier, Marcus Hentrich, Bernd Hertenstein, Brigitte Schnabel, Wolfram Jung, Tobias Dechow, Ralf Bargou, Sigrid Adler-Reichel, Holger Hebart, Albrecht Reichle, Martin Gramatzki, Michael Pfreundschuh, Bertold Emmerich, Norbert Frickhofen, Else Heidemann, Hannes Wandt, Axel Hinke, Hermann Einsele, Peter Liebisch, Nicola Lang, Burkhard Hennemann, Tim Hendrik Bruemmendorf, Martin Bentz, Christian Straka, Lorenz Trümper, Hans Salwender, Bernd Metzner, Kerstin Schäfer-Eckart, Andreas Sandermann, Stefan Knop, Helga Bernhard
Autologous transplantation is controversial for older patients with multiple myeloma. The role of age-adjusted high-dose melphalan and the impact of preceeding induction chemotherapy cycles has been unclear. A total of 434 patients 60 to 70 years of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a824e7ef8ea912a0ea7bc95281cb8f66
https://doi.org/10.3324/haematol.2016.151860
https://doi.org/10.3324/haematol.2016.151860
Autor:
Knut Wendelin, Markus Schaich, Christian Junghanss, Anthony D. Ho, Kerstin Schaefer-Eckart, Hannes Wandt, Ulrich Mahlknecht, Gerhard Ehninger, Mathias Hänel, Lothar Leimer, Michael Kramer, Martin Wilhelm, Regina Herbst, Rainer Schwerdtfeger, Gottfried Dölken, Bettina Pilz, Martin Kaufmann, Anne Friederike Klenner, Markus Thalheimer, Roland Conradi
Publikováno v:
The Lancet. 380:1309-1316
Summary Background Routine prophylactic platelet transfusion is the standard of care for patients with severe thrombocytopenia. We assessed the effect of a new strategy of therapeutic platelet transfusion on the number of transfusions and safety in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67b1d425e5fde96cf783f95d17b26d41
https://doi.org/10.1016/s0140-6736(12)60689-8
https://doi.org/10.1016/s0140-6736(12)60689-8
Autor:
Gerhard Ehninger, Reingard Stuhlmann, Norbert Schmitz, Martin Bornhäuser, Silke Soucek, Heinrich Bodenstein, Alwin Krämer, Martin Kaufmann, Anthony D. Ho, Joachim Tischler, Michael Kramer, Christian Thiede, Christoph Röllig, Hannes Wandt, Johannes Schetelig, Brigitte Mohr, Kerstin Schäfer-Eckart, Walter E. Aulitzky, Markus Schaich, Uta Oelschlaegel
Publikováno v:
Journal of Clinical Oncology. 29:2696-2702
Purpose To assess the optimal cumulative dose of cytarabine for treatment of young adults with acute myeloid leukemia (AML) within a prospective multicenter treatment trial. Patients and Methods Between 1996 and 2003, 933 patients (median age, 47 yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6b3e3b0c7553949cfcf0eb25d3f4864
https://doi.org/10.1200/jco.2010.33.7303
https://doi.org/10.1200/jco.2010.33.7303
Autor:
Marcus Hentrich, Michael Sandherr, Gerhard Ehninger, Bertold Emmerich, Christof Scheid, Andreas Engert, Alexander Giagounidis, Bernd Metzner, Gerda Silling, Wolfgang Grimminger, Kai Hübel, Rainer Schwerdtfeger, Hans Salwender, Orhan Sezer, Günter Schlimok, Christian Straka, Harald Heinisch, Axel Hinke, Hermann Einsele, Peter Hellmann, Mathias Freund, Hannes Wandt, Daniel Franke
Publikováno v:
Blood. 117:2121-2128
The individual risk of infection and requirements for medical treatment after high-dose chemotherapy have been unpredictable. In this prospective, multicenter, open-label study we investigated the potential of granulocyte colony-stimulating factor (G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f8e428588f88369f7a738a59011c97
https://doi.org/10.1182/blood-2010-06-290080
https://doi.org/10.1182/blood-2010-06-290080